The ability of tumor cells to develop simultaneous resistance to structurally different cytotoxic drugs constitutes a major problem in cancer chemotherapy. It was previously demonstrated that multidrug-resistant Chinese hamster cell lines contain an amplified, transcriptionally active DNA sequence designated mdr. This report presents evidence that multidrug-resistant sublines of human KB carcinoma cells, selected for resistance to either colchicine, vinblastine, or Adriamycin (doxorubicin), display amplification of two different DNA sequences homologous to the hamster mdr gene. Segments of the human mdr DNA sequences, designated mdrl and mdr2, have been cloned. mdrl sequences were amplified in all of the highly drug-resistant sublines and were expressed as a poly(A)+ RNA species of 4.5 kilobases that was detected in the resistant cells but not in the parental cell line. No expression of mdr2 sequences was detected. mdr2 sequences were coamplified with mdrl in some of the multidrug-resistant sublines and, in two independently derived cell lines, underwent very similar rearrangements. The data suggest that the mdrl gene is involved in multidrug resistance in human cells.
Selection of mammalian cells for resistance to plant alkaloids or antitumor antibiotics frequently results in the development of cross-resistance to other drugs unrelated in their structure and mode of action to the original selective agent. The phenomenon of multidrug resistance constitutes a major problem in cancer chemotherapy because it involves resistance to some of the most commonly used anticancer drugs, such as anthracyclines, Vinca alkaloids, epipodophyllotoxins, and actinomycin D. Multidrug resistance has been shown in most cases to result from decreased intracellular drug accumulation, apparently as a result of alterations in the plasma membrane (1) (2) (3) . In many multidrug-resistant cell lines, the resistance was found to correlate with overexpression of a 170-kDa membrane glycoprotein and, in some cases, a 19-to 21-kDa cytosolic protein (1) (2) (3) (4) (5) (6) .
Two different multidrug-resistant Chinese hamster cell lines selected for resistance to either colchicine or Adriamycin (doxorubicin) have amplified a common region of DNA (7, 8) . This region was found to contain a transcription unit, presently designated mdr, that encodes an mRNA of -5 kilobases (kb). Expression of this mRNA correlates with multidrug resistance in hamster cells (8) . Riordan et al. (9) reported that the gene encoding a 170-kDa membrane glycoprotein (P-glycoprotein) is also amplified in several multidrug-resistant mammalian cell lines. The relationship between mdr and the P-glycoprotein gene is still unknown.
To analyze the mechanism of multidrug resistance in human tumor cells, we have isolated sublines of the human KB carcinoma cell line, selected for resistance to colchicine, vinblastine, or Adriamycin. These sublines display decreased accumulation of various drugs with increased drug efflux and several biochemical changes (10) (11) (12) (13) . By use of the in-gel DNA-renaturation technique (14) , some of the multidrugresistant sublines of KB cells were shown to contain amplified DNA sequences, and karyotypic analysis revealed double minute chromosomes (15) . In the present study, we report that multidrug-resistant KB cell lines have amplified two related DNA sequences that are homologous to the Chinese hamster mdr gene. One of these sequences (mdrl) is amplified in all sublines selected for a high degree of resistance to colchicine, vinblastine, or Adriamycin and is expressed in multidrug-resistant cells.
MATERIALS AND METHODS
DNA Extraction and Southern Hybridization. DNA from the cell lines was extracted as described (15, 16) and was digested with 5 units of restriction enzymes as recommended by the supplier. In most experiments, the concentration of digested DNA was determined by the diphenylamine reaction (17) . Five micrograms of each DNA digest was electrophoresed in an agarose gel and transferred onto a Biodyne membrane (Pall, East Hills, NY) by the procedure of Southern (18) . Gel-purified inserts of the appropriate plasmid clones were labeled with 32P to a specific activity of 1-3 x 109 dpm/pug by "oligolabeling" (19) and used as probes at a concentration 2-4 x 105 dpm/cm2. Hybridization was performed under conditions recommended by the manufacturer. After hybridization, the membranes were washed with 4x SSC (lx SSC is 0.15 M NaCl/15 mM trisodium citrate, pH 7.0)10.5% NaDodSO4 at 650C (low stringency) or 0.1 X SSC/0.5% NaDodSO4 at 650C (high stringency) and autoradiographed. To confirm the absence of plasmid contamination in human DNA preparations, each blot was rehybridized with 32P-labeled pSP64 plasmid vector. For quantitation of gene copy number, the intensities ofbands in autoradiograms were estimated by densitometer tracing and computation of the areas of the corresponding peaks.
Cloning Procedures. Restriction mapping and subcloning into the pSP64 plasmid vector were performed by standard procedures (20) . Plasmid DNA was isolated by alkaline lysis (21) . Genomic libraries were constructed by digesting 0.5 Ag of KB-C3 DNA to completion with either EcoRI or HindIII, followed by ligation into the single EcoRI site of the phage vector Xgtll (22) or the single HindIII site of phage Charon 28 (23) . The insertion-cloning strategy provided for selective cloning of the fragments smaller than 7 kb (for EcoRI) or 11 kb (for HindIII). Plaques (105) of each library were screened with the gel-purified insert of pDR4.7 hamster mdr clone by Abbreviation: kb, kilobase(s).
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. plaque hybridization (24) . Positive phages were plaquepurified and phage DNA was isolated (25) , and the inserts were recloned in pSP64. To locate highly repeated sequences, cloned DNA was digested with several restriction enzymes and hybridized by the procedure of Southern with 32P-labeled total DNA (0.35 x 105 dpm/cm2) from human peripheral blood cells.
RNA Isolation and Analysis. Poly(A)+ RNA was extracted as described (26) . One microgram of each RNA preparation was electrophoresed in a glyoxal/1.5% agarose gel (27) , transferred onto GeneScreenPlus membranes, and hybridized with the appropriate 32P-labeled probes at 3 x 105 dpm/cm2. Hybridization was done at 420C in 1 M NaCl/10% dextran sulfate/1% NaDodSO4/50% (vol/vol) formamide containing denatured salmon sperm DNA at 100 Ag/ml. The membranes were washed with 0.1 x SSC/0.5% NaDodSO4 at 650C and autoradiographed. Sizes of RNA species were determined relative to the positions of 28S and 18S rRNA. To control for variation in sample size, the filters were rehybridized with a dihydrofolate reductase cDNA clone (28) .
RESULTS
Amplification of Human mdr DNA Sequences in MultidrugResistant Cell Lines. The Chinese hamster mdr DNA sequences used in this study were derived from the cosmid clone cosDR3A, containing a 5' segment of the hamster mdr gene (8) . After digestion with the restriction enzymes Xba I and Kpn I, individual restriction fragments of 1.5-6 kb were subcloned in a pSP64 plasmid vector ( Fig. la) The subclones were then used as probes for hybridization with restriction digests of human genomic DNA. Most probes, when used under conditions of low hybridization stringency, produced either no hybridization signal or a continuous smear suggesting hybridization with human repetitive DNA sequences (data not shown). Only one of the cosDR3A subclones, containing a 4.7-kb Xba I fragment and designated pDR4.7 ( Fig. la) , gave rise to distinct bands when hybridized to human DNA under low-stringency conditions ( Fig. 1 b and  c ). This subclone, containing the relatively conserved DNA sequences, was employed as a probe in subsequent experiments.
To determine whether the mdr gene was amplified in multidrug-resistant human cells, DNA extracted from the parental KB-3-1 cells, the multidrug-resistant sublines, and a revertant (KB-Cl-Ri) described in Table 1 was digested with EcoRI or HindIII, electrophoresed in agarose gels, and hybridized to the pDR4.7 probe (8). pDR4.7 hybridized to two EcoRI fragments (13.5 and 4.5 kb, All of these fragments were amplified in colchicine-selected sublines KB-8-5-11, KB-8-5-11-24, KB-C3, and KB-C4 but not in the revertant subline KB-Cl-Ri. Unlike the colchicineselected sublines, the subline KB-Vl, selected in vinblastine, showed amplification of only the 13.5-kb EcoRI and 4.4-kb HindIII bands. In the Adriamycin-resistant cells KB-Al and KB-A2, these two bands were also amplified. KB-Al contained a new amplified band of 7 kb in the EcoRI digest and of 6.5 kb in the HindIII digest. The same bands were present in KB-Vl, but they were not amplified. No bands of this size were detected in the parental KB-3-1 DNA, suggesting they arose as a result of DNA rearrangement.
The different patterns of amplification of the two types of bands hybridizing to the hamster mdr probe in different sublines suggested that they might correspond to two different related DNA sequences, possibly different members of a multigene family, rather than to two different parts of one contiguous hybridizing region. DNA sequences corresponding to the 13. (Fig. 1c) Derivation and characterization of multidrug-resistant sublines of KB cells have been described (10) (11) (12) (13) . KB-8-5-11, KB-8-5-11-24, KB-C3, and KB-C4 are subclones selected in medium containing colchicine at 0.1, 1, 3, and 4 ,ug/ml, respectively. KB-Cl-Ri is a revertant of colchicine-resistant KB-C1 cells, cloned from a population growing in the absence of colchicine. KB-Vl was selected in multiple steps and is resistant to vinblastine at 1 ug/ml. KB-Al and KB-A2 are resistant to Adriamycin at 1 ug/ml and 2 ,tg/ml, respectively. Since the drug-resistance phenotype is unstable, cell lines are maintained in medium with selecting concentrations of drug. Relative resistance is expressed as the LD10 of the resistant line divided by the LD10 of the parental KB-3-1 cells (10) . Amplification is the copy number of the corresponding DNA sequences in multidrug-resistant cell lines relative to the parental KB-3-1 cells. ND, not determined. *mdr2 DNA sequences are rearranged (see text).
mdrl and mdr2 sequences appear to be amplified to a similar degree in these cells. The loss of amplified mdr sequences in a revertant of a multidrug-resistant cell line (KB-C1-Rl) provides strong additional evidence that mdr gene amplification underlies multidrug resistance in the highly resistant cells.
Cloning of Human mdrl and mdr2 DNA Sequences. To investigate the nature of the human mdr genes, we have cloned the 4.4-kb HindIII fragment of mdrl and the 4.5-kb EcoRI fragment of mdr2 from the DNA of subline KB-C3. The EcoRI library was constructed by insertion into the EcoRI site of the Xgtll phage vector (22) , and the HindIII library was made by insertion into the HindIII site of Charon 28 (23) . Both libraries were screened by plaque hybridization (24) with the Chinese hamster pDR4.7 probe. A clone containing the 4.4-kb fragment of mdrl was isolated from the HindIII library, and a clone containing the 4.5-kb fragment of mdr2 was isolated from the EcoRI library. Both inserts were subsequently recloned in the plasmid vector pSP64 (20) , giving rise to plasmid clones designated pHDR4.4 and pHDR4.5, respectively. Restriction maps of these clones are shown in Fig. 2a . Subfragments of pHDR4.4 and pHDR4.5 free of highly repeated sequences were identified by their failure to hybridize to 32P-labeled human genomic DNA (data not shown). Hybridization with the pDR4.7 hamster probe (not shown) permitted localization of the conserved sequences within the clones (Fig. 2a) . The regions of pHDR4.4 and pHDR4.5 hybridizing with the hamster probe were also found to cross-hybridize with each other under conditions of low stringency (Fig. 2b) .
We subcloned those repeat-free fragments of both clones that hybridized to pDR4.7 into the plasmid pSP64 (Fig. 2a) . The clone containing a 0.8-kb Pvu II fragment of pHDR4.4, inserted into the Sma I site of the vector, was designated pMDR1. The clone containing a 1.0-kb Pst I fragment of pHDR4.5, inserted into the Pst I site of the vector, was designated pMDR2. was digested with HindIII and hybridized to either the hamster pDR4.7 probe under conditions of low hybridization stringency or to the human pMDR1 or pMDR2 probes at high hybridization stringency (Fig. 3) . The rearranged bands in both KB-Al and KB-V1 sublines correspond to mdr2. Both types of cells also contain mdr2-hybridizing bands of the same size as in the parental cell line, 10.5 kb, suggesting that only one allele of the mdr2 locus was rearranged. The mobility of the rearranged bands is also identical in KB-V1 and KB-Al DNA digested with EcoRI or Stu I (Fig. 4; 7 .0-kb EcoRI band and 3.9-kb Stu I band) as well as with several other restriction enzymes (data not shown), thus indicating that a similar or identical rearrangement may have occurred in both independently selected sublines. This rearrangement has been mapped to the 0.9-kb BamHI-EcoRI fragment of pHDR4.5 (the rightmost region in Fig. 2a) . However, although the rearranged sequences are amplified in KB-Al, they do not appear amplified in KB-V1 cells. Further, in the subline KB-A2, the rearranged mdr2 band is no longer detectable. In the EcoRI digest of KB-Al DNA (Fig. 4) , in addition to the rearranged and amplified 7-kb and parental 4.5-kb mdr2 bands, two other weak bands, which may Proc. Natl. Acad. Sci. USA 83 (1986) (Fig. 5) . This mRNA was not detected in the parental KB-3-1 cells. No mdr2-specific RNA was found using either pMDR2 (Fig. 5) gene always amplified in multidrug-resistant cell lines. Amplification of the human mdrl gene during selection for increased drug resistance and the loss of amplified mdrl DNA in a revertant cell line strongly indicate that mdrl or a closely linked amplified gene is responsible for multidrug resistance. It appears likely that mdrl rather than another gene represents the essential part of the amplified region, since mdr DNA sequences were found to be amplified and overexpressed in all multidrug-resistant human, hamster (7), or mouse (unpublished data) cell lines so far tested. Finally, the transfer of the human mdrl gene but not the mdr2 gene is linked to the acquisition of multidrug resistance in mouse NIH 3T3 cells transfected with DNA from multidrug-resistant human KB cells (unpublished data).
The correlation between the degree of mdrl DNA amplification and relative drug resistance varies among different independently selected sublines of KB cells (Table 1 ). In addition, the copy number of mdr genes is reduced to apparently single-copy level in the revertant cell line KBCl-R1, even though this cell line maintains a 3-to 6-fold level of relative drug resistance. We have recently found (30) that the KB-C1-R1 cell line, as well as the KB sublines corresponding to the first two steps of selection with colchicine (10), have elevated expression of mdrl RNA in the absence of mdrl gene amplification, suggesting that transcriptional activation of mdrl may precede its amplification during the development of resistance. The existence of two differentially amplified human DNA sequences that cross-hybridize with the hamster mdr gene suggests that human mdr DNA sequences may comprise a multigene family. Different cross-hybridizing mdr sequences have also been observed in hamster and mouse DNA (ref. 8 and unpublished data). Riordan et al. (9) have also suggested that the gene for hamster P-glycoprotein, which may be identical with mdr, is a member of a multigene family. If mdrl and mdr2 are linked in the genome, amplification of mdr2 DNA sequences in multidrug-resistant cell lines could be explained as coamplification of DNA sequences flanking the essential mdrl gene. By digesting human DNA with infrequently cutting restriction enzymes and utilizing pulsed-field gradient gel electrophoresis (31) for separation of very large DNA fragments, we have found that mdrl and mdr2 are linked within 350 kb of DNA in KB-C3 cells (unpublished data).
DNA rearrangements have been frequently associated with gene amplification (8, 32) . The rearrangement of mdr DNA sequences in KB-Al and KB-V1 cells is unusual, however, in that the rearranged bands appear to be identical or nearly identical in these independently derived cell lines.
The nature of the protein encoded by the mdr gene(s) is still unknown. Several lines of evidence suggest that mdr DNA sequences may be identical or related to the gene for the 170-kDa membrane glycoprotein (P-glycoprotein), a cDNA clone of which was recently isolated from Chinese hamster cells (9) , Both mdr and the P-glycoprotein gene encode a 4.5-kb mRNA. Both genes were found to be amplified in two independently derived sets of multidrug-resistant Chinese hamster cells (7, 9) , as well as in a multidrug-resistant human leukemia cell line (9, 30) . The sublines of human KB cells used in the present study were found by immunoblotting assay using an anti-P-glycoprotein monoclonal antibody (33) to have an increased amount of P-glycoprotein in their membranes (13) .
It is not known whether mdr genes are involved in the development of multidrug resistance by human tumor cells both in vitro and in vivo and whether the same genes are responsible for tumor resistance acquired in the course of drug treatment observed in some untreated tumors. The availability of cloned probes that detect transcription of mdr DNA in human cells makes it possible now to investigate the expression of these sequences in clinical samples of multidrug-resistant tumors.
